Trends in annual medicare expenditures for glaucoma surgical procedures from 1997 to 2006

Archives of Ophthalmology

Volumn 127, Issue 7, 2009, Pages 900-905

  Schmier, Jordana K ^a   Covert, David W ^b   Lau, Edmund C ^a   Robin, Alan L ^c  

^a EXPONENT INC   (United States)

^b ALCON RESEARCH LTD   (United States)

^c UNIVERSITY OF MARYLAND   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BILLING AND CLAIMS; EVALUATION; FEMALE; GLAUCOMA; HEALTH CARE COST; HUMAN; LASER COAGULATION; MAJOR CLINICAL STUDY; MALE; MEDICARE; PRIORITY JOURNAL; REIMBURSEMENT; RETROSPECTIVE STUDY; SHUNTING; SURGICAL TECHNIQUE; TECHNOLOGY; TRABECULECTOMY; TRABECULOPLASTY; UNITED STATES;

CENTERS FOR MEDICARE AND MEDICAID SERVICES (U.S.); CURRENT PROCEDURAL TERMINOLOGY; FILTERING SURGERY; GLAUCOMA; HEALTH CARE COSTS; HEALTH EXPENDITURES; HEALTH SERVICES RESEARCH; HUMANS; IRIDECTOMY; IRIS; LASER COAGULATION; MEDICARE PART B; PHYSICIAN'S PRACTICE PATTERNS; RETROSPECTIVE STUDIES; UNITED STATES;

EID: 67650462707     PISSN: 00039950     EISSN: 15383601     Source Type: Journal    
DOI: 10.1001/archophthalmol.2009.122     Document Type: Article

References (43)

1. Quigley HA, Broman AT. The number of people with glaucoma worldwide in 2010 and 2020. Br J Ophthalmol. 2006;90(3):262-267.
2. Resnikoff S, Pascolini D, Mariotti SP, Pokharel GP. Global magnitude of visual impairment caused by uncorrected refractive errors in 2004. Bull World Health Organ. 2008;86(1):63-70.
3. American Academy of Ophthalmology. Preferred Practice Pattern. Primary Open-Angle Glaucoma. Limited Revision. San Francisco, CA: American Academy of Ophthalmology; 2003.
4. Tuck MW, Crick RP. The age distribution of primary open angle glaucoma. Ophthalmic Epidemiol. 1998;5(4):173-183.
5. Duggal P, Klein AP, Lee KE, et al. A genetic contribution to intraocular pressure: the Beaver Dam Eye Study. Invest Ophthalmol Vis Sci. 2005;46(2):555-560.
6. Quigley HA, Vitale S. Models of open-angle glaucoma prevalence and incidence in the United States. Invest Ophthalmol Vis Sci. 1997;38(1):83-91.
7. Hitzl W, Bunce C, Reitsamer HA, Grabner G, Hornykewycz K. The projected increase in glaucoma due to the aging population in Austria from 2001 to 2031. Eur J Ophthalmol. 2007;17(1):45-52.
8. Tuck MW, Crick RP. The projected increase in glaucoma due to an ageing population. Ophthalmic Physiol Opt. 2003;23(2):175-179.
9. Schappert SM. Office visits for glaucoma: United States, 1991-92. Adv Data. 1995;(262):1-14.
10. Rein DB, Zhang P, Wirth KE, et al. The economic burden of major adult visual disorders in the United States. Arch Ophthalmol. 2006;124(12):1754-1760.
11. Lee PP, Walt JG, Doyle JJ, et al. A multicenter, retrospective pilot study of resource use and costs associated with severity of disease in glaucoma. Arch Ophthalmol. 2006;124(1):12-19.
12. Salm M, Belsky D, Sloan FA. Trends in cost of major eye diseases to Medicare, 1991 to 2000. Am J Ophthalmol. 2006;142(6):976-982.
13. Ramulu PY, Corcoran KJ, Corcoran SL, Robin AL. Utilization of various glaucoma surgeries and procedures in Medicare beneficiaries from 1995 to 2004. Ophthalmology. 2007;114(12):2265-2270.
14. Data series CWUR0000SAM2. Bureau of Labor Statistics Web site. www.bls.gov. Accessed October 14, 2007.
15. Escarce JJ. Effects of lower surgical fees on the use of physician services under Medicare. JAMA. 1993;269(19):2513-2518.
16. Mitchell JM, Hadley J, Gaskin DJ. Spillover effects of Medicare fee reductions: evidence from ophthalmology. Int J Health Care Finance Econ. 2002;2(3):171-188.
17. Mitchell JM, Hadley J, Gaskin DJ. Physicians' responses to Medicare fee schedule reductions. Med Care. 2000;38(10):1029-1039.
18. Shrank W, Ettner SL, Slavin PH, Kaplan HJ. Effect of physician reimbursement methodology on the rate and cost of cataract surgery. Arch Ophthalmol. 2005;123(12):1733-1738.
19. Ellwein LB, Urato CJ. Use of eye care and associated charges among the Medicare population: 1991-1998. Arch Ophthalmol. 2002;120(6):804-811.
20. Paikal D, Yu F, Coleman AL. Trends in glaucoma surgery incidence and reimbursement for physician services in the Medicare population from 1995 to 1998. Ophthalmology. 2002;109(7):1372-1376.
21. Goulet RJ III, Phan AD, Cantor LB, WuDunn D. Efficacy of the Ahmed S2 glaucoma valve compared with the Baerveldt 250-mm2 glaucoma implant. Ophthalmology. 2008;115(7):1141-1147.
22. Rachmiel R, Trope GE, Chipman ML, Gouws P, Buys YM. Laser trabeculoplasty trends with the introduction of new medical treatments and selective laser trabeculoplasty. J Glaucoma. 2006;15(4):306-309.
23. Huang MC, Netland PA, Coleman AL, Siegner SW, Moster MR, Hill RA. Intermediate-term clinical experience with the Ahmed Glaucoma Valve implant. Am J Ophthalmol. 1999;127(1):27-33.
24. Gayton JL, Van Der Karr M, Sanders V. Combined cataract and glaucoma surgery. J Cataract Refract Surg. 1999;25(9):1214-1219.
25. Strutton DR, Walt JG. Trends in glaucoma surgery before and after the introduction of new topical glaucoma pharmacotherapies. J Glaucoma. 2004;13(3):221-226.
26. Brown MM, Brown GC, Spaeth GL. Improper topical self-administration of ocular medication among patients with glaucoma. Can J Ophthalmol. 1984;19(1):2-5.
27. Robin AL, Covert D. Does adjunctive glaucoma therapy affect adherence to the initial primary therapy? Ophthalmology. 2005;112(5):863-868.
28. Robin AL, Novack GD, Covert DW, Crockett RS, Marcic TS. Adherence in glaucoma. Am J Ophthalmol. 2007;144(4):533-540.
29. Rachmiel R, Trope GE, Chipman ML, Gouws P, Buys YM. Effect of medical therapy on glaucoma filtration surgery rates in Ontario. Arch Ophthalmol. 2006;124(10):1472-1477.
30. Rachmiel R, Trope GE, Chipman ML, Buys YM. Cataract surgery rates in Ontario, Canada, from 1992 to 2004: more surgeries with fewer ophthalmologists. Can J Ophthalmol. 2007;42(4):539-542.
31. Coleman AL, Morgenstern H. Use of insurance claims databases to evaluate the outcomes of ophthalmic surgery. Surv Ophthalmol. 1997;42(3):271-278.
32. Javitt JC, McBean AM, Sastry SS, DiPaolo F. Accuracy of coding in Medicare part B claims: cataract as a case study. Arch Ophthalmol. 1993;111(5):605-607.
33. Virnig BA, Morgan RO, DeVito CA, Persily NA. Medicare HMOs: who joins and who leaves? Am J Manag Care. 1998;4(4):511-518.
34. Morgan RO, Virnig BA, DeVito CA, Persily NA. The Medicare-HMO revolving door - the healthy go in and the sick go out. N Engl J Med. 1997;337(3):169-175.
35. Revere L, Sear A. Differences in US hospital service utilization between traditional Medicare and Medicare HMO patients. J Health Hum Serv Adm. 2004;27(3):347-374.
36. Revere L, Large J, Langland-Orban B. A comparison of inpatient severity, average length of stay, and cost for traditional fee-for-service Medicare and Medicare HMOs in Florida. Health Care Manage Rev. 2004;29(4):320-328.
37. Stern RS, Juhn PI, Gertler PJ, Epstein AM. A comparison of length of stay and costs for health maintenance organization and fee-for-service patients. Arch Intern Med. 1989;149(5):1185-1188.
38. Dhanani N, O'Leary JF, Keeler E, Bamezai A, Melnick G. The effect of HMOs on the inpatient utilization of Medicare beneficiaries. Health Serv Res. 2004;39(5):1607-1627.
39. Bhosle MJ, Reardon G, Camacho FT, Anderson RT, Balkrishnan R. Medication adherence and health care costs with the introduction of latanoprost therapy for glaucoma in a Medicare managed care population. Am J Geriatr Pharmacother. 2007;5(2):100-111.
40. Gieser DK, Tracy Williams R, O'Connell W, et al. Costs and utilization of end-stage glaucoma patients receiving visual rehabilitation care: a US multisite retrospective study. J Glaucoma. 2006;15(5):419-425.
41. Javitt JC, Zhou Z, Willke RJ. Association between vision loss and higher medical care costs in Medicare beneficiaries costs are greater for those with progressive vision loss. Ophthalmology. 2007;114(2):238-245.
42. Schmier JK, Halpern MT, Jones ML. The economic implications of glaucoma: a literature review. Pharmacoeconomics. 2007;25(4):287-308.
43. Rouland JF, Berdeaux G, Lafuma A. The economic burden of glaucoma and ocular hypertension. Drugs Aging. 2005;22(4):315-321.